Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berrocal

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 17, 2015
SEOM guidelines for the management of Malignant Melanoma 2015A Berrocal, A Arance, E Espinosa, et al.
American Journal of Clinical Oncology|December 1, 1996
Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, SpainJ Feliu, M González Barón, C García Girón, et al.
Journal of Neuro-Oncology|December 20, 2013
Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistryOscar Gallego, M Cuatrecasas, M Benavides, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 9, 2017
SEOM clinical guideline for the management of malignant melanoma (2017)A Berrocal, A Arance, V E Castellon, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 3, 2015
A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastomaJ M Sepúlveda, C Belda-Iniesta, M Gil-Gil, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2020
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)M Majem, E García-Martínez, M Martinez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 18, 2016
Safety of vemurafenib in patients with BRAF <sup>V600</sup> mutated metastatic melanoma: the Spanish experienceA M Arance, A Berrocal, J A Lopez-Martin, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 2, 2021
SEOM clinical guideline for the management of cutaneous melanoma (2020)M Majem, J L Manzano, I Marquez-Rodas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancerR Hitt, J J Grau, A López-Pousa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 17, 2013
Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyS Martín-Algarra, M T Fernández-Figueras, J A López-Martín, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 17, 2015
SEOM guidelines for the management of Malignant Melanoma 2015A Berrocal, A Arance, E Espinosa, et al.
American Journal of Clinical Oncology|December 1, 1996
Phase II study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, SpainJ Feliu, M González Barón, C García Girón, et al.
Journal of Neuro-Oncology|December 20, 2013
Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistryOscar Gallego, M Cuatrecasas, M Benavides, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 9, 2017
SEOM clinical guideline for the management of malignant melanoma (2017)A Berrocal, A Arance, V E Castellon, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 3, 2015
A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastomaJ M Sepúlveda, C Belda-Iniesta, M Gil-Gil, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 30, 2020
SEOM clinical guideline for the management of immune-related adverse events in patients treated with immune checkpoint inhibitors (2019)M Majem, E García-Martínez, M Martinez, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 18, 2016
Safety of vemurafenib in patients with BRAF <sup>V600</sup> mutated metastatic melanoma: the Spanish experienceA M Arance, A Berrocal, J A Lopez-Martin, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 2, 2021
SEOM clinical guideline for the management of cutaneous melanoma (2020)M Majem, J L Manzano, I Marquez-Rodas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2013
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancerR Hitt, J J Grau, A López-Pousa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 17, 2013
Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyS Martín-Algarra, M T Fernández-Figueras, J A López-Martín, et al.
Pageof 11